Related references
Note: Only part of the references are listed.Clinical Features of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia versus Those of Methicillin-Resistant S. aureus Bacteremia
Yasmin Maor et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype
Brian T. Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus
Benjamin P. Howden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia
Benjamin P. Howden et al.
BMC MICROBIOLOGY (2008)
Effect of tumor necrosis factor-α on intracellular Staphylococcus aureus in vascular endothelial cells
Wan Beom Park et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2008)
Evaluation of a new etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA
Anne Yusof et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)
Michael J. Rybak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients
Tahaniyat Lalani et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
agr-mediated dispersal of Staphylococcus aureus biofilms
Blaise R. Boles et al.
PLOS PATHOGENS (2008)
Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance
Hui-Min Neoh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant staphylococcus aureus
Pedro M. Pereira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia
Pamela A. Moise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells
Christian Garzoni et al.
BMC GENOMICS (2007)
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing
Michael M. Mwangi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm
Issam Raad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Prevalence and charactenistics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center
Yasmin Maor et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus
Brian T. Tsuji et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism:: Implications for polysaccharide intercellular adhesin synthesis and autolysis
Jennifer L. Nelson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus
Maritza Barcia-Macay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacterernia
Benjamin P. Howden et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages
M Barcia-Macay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Inhibition of the autolytic system by vancomycin causes mimicry of vancomycin-intermediate Staphylococcus aureus-type resistance, cell concentration dependence of the MIC, and antibiotic tolerance in vancomycin-susceptible S-aureus
K Sieradzki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S-aureus-type resistance to vancomycin
F McAleese et al.
JOURNAL OF BACTERIOLOGY (2006)
Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus
LZ Cui et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Unstable vancomycin heteroresistance is common among clinical isolates of methiciliin-resistant Staphylococcus aureus
N Plipat et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Acetic acid induces expression of the Staphylococcus aureus cidABC and lrgAB murein hydrolase regulator operons
KC Rice et al.
JOURNAL OF BACTERIOLOGY (2005)
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility
BP Howden et al.
CLINICAL INFECTIOUS DISEASES (2004)
SOS response induction by β-lactams and bacterial defense against antibiotic lethality
C Miller et al.
SCIENCE (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Prevalence, molecular epidemiology, and clinical significance of heterogeneous glycopeptide-intermediate Staphylococcus aureus in liver transplant recipients
F Bert et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Genome-wide transcriptional profiling of the response of Staphylococcus aureus to cell-wall-active antibiotics reveals a cell-wall-stress stimulon
S Utaida et al.
MICROBIOLOGY-SGM (2003)
Staphylococcus aureus with heterogeneous resistance to vancomycin:: Epidemiology, clinical significance, and critical assessment of diagnostic methods
C Liu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus
K Sieradzki et al.
JOURNAL OF BACTERIOLOGY (2003)
Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin
G Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea
MN Kim et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)